1Brookmeyer R, Gray S, Kawas C. Projections of Alzheimer' s disease in the United States and the public health impact of delaying disease onset. Am J Public Health, 1998, 88: 1337- 1342.
2Zhang ZX, Zahner GE, Roman GC, et al. Dementia subtypes in China: prevalence in Beijing, Xian, Shanghai, and Chengdu. Arch Neurol, 2005,62 : 447-453.
3Zhang ZX, Zahner GE, Roman GC, et al. Socio-demographic variation of dementia subtypes in China: methodology and results of a prevalence study in Beijing, Chengdu, Shanghai, and Xian. Neuroepidemialogy, 2006,27 : 177-187.
4Ferri CP, Prince M, Brayne C, et al. Global prevalence of dementia: a Delphi consensus study. Lancet, 2005,366: 2112- 2117.
10Samochocki M,Hoffle A,Fehrenbacher A,et al.Galantamine is an allosterically potentiating ligand of neuronal nicotinic but not of muscarinic acetylcholine receptors.J Pharmacol Exp Ther,2003,305:1024-1036.
4Yeguang Wu1,Guobing Zhang1,Chunlin Zhang1,Zhibin Li1,Chenghan Wei2,Jinchao Chen3, Donglan Huang2,Rong Zhao1,Jinrui Huang1,Bin Wei2,Xiaoming Zhang2 1Department of Psychiatry, Nanning Social Welfare Hospital, Nanning 530003, Guangxi Zhuang Autonomous Region, China,2Department of Psychiatry, Jiulong Railway Hospital, Yizhou 546300, Guangxi Zhuang Autonomous Region, China,3Longevous Institute, Bama 546500, Guangxi Zhuang Autonomous Region, China.Cognitive function of 320 people over 65 years from longevous areas in Guangxi Zhuang Autonomous Region: Feasibility of the mini-mental state examination[J].Neural Regeneration Research,2006,1(9):797-800.
